The Same Concentration, Different Compounds
Two drinking water sources, each with total PFAS concentrations measured at 50 ng/L, may present entirely different treatment challenges depending on which compounds make up that total. A source water where 50 ng/L is composed primarily of PFOS and PFOA will respond well to GAC treatment with established bed-volume performance data and reliable service life prediction. A source water where the same 50 ng/L is composed primarily of PFBS, PFHxA, and PFPeA — all short-chain compounds — will require different treatment technology and a different operational strategy. Compound-level characterization, not just total concentration, is the foundational input to effective PFAS treatment design.
Urban and rural drinking water sources show systematically different PFAS compound profiles that reflect the distinct contamination sources present in each setting. Understanding these differences at a population level is not just academically interesting — it has direct implications for national treatment policy, local procurement decisions, and the adequacy of regulatory frameworks that focus monitoring and remediation on the most common legacy compounds.
Urban PFAS Profiles: Diverse Sources, Mixed Compounds
Urban water sources — surface water intakes, groundwater wells, and reservoir systems in densely populated areas — receive PFAS inputs from multiple overlapping sources. Stormwater runoff carries PFAS from building materials, road surfaces, and impervious cover. Wastewater treatment plant effluent contributes PFAS from household products, personal care products, and industrial pretreaters. Urban AFFF use at city fire stations and airport operations adds point-source contamination. The compound profile that results from this multiple-source urban input tends to be diverse: a mixture of long-chain legacy PFAS from older inputs, short-chain PFAS from current-generation consumer products, and precursor compounds from AFFF use.
Urban water utilities with robust PFAS monitoring programs typically document 10 to 20 distinct PFAS compounds at quantifiable concentrations, with no single compound dominating the profile. This diversity means that treatment technology selection must consider performance across a wide compound range. PFAS-selective media that performs consistently across compound classes is often a better fit for urban source water than technology optimized for the specific legacy compounds that historical monitoring programs emphasized.
Rural PFAS Profiles: Point Sources and Short-Chain Dominance
Rural drinking water sources are more likely to show profiles dominated by specific compound classes that reflect the primary contamination source in the local geography. Agricultural areas with biosolid application history show profiles dominated by short-chain PFCAs — PFBS, PFPeA, PFHxA — because these are the compounds that accumulate in biosolids and leach readily through soil. Rural areas near military installations show PFOS- and PFHxS-dominated profiles characteristic of ECF-derived AFFF. Rural areas adjacent to fluorochemical manufacturing show profiles reflecting current production chemistry.
The rural context also affects treatment implementation. Private well owners and small community water systems (those serving fewer than 500 connections) have limited technical capacity and capital resources for water treatment infrastructure. Point-of-use treatment — under-sink filters or whole-home systems — is often the most practical option. The effectiveness of point-of-use PFAS-selective media for short-chain compound removal is therefore a critical public health question for rural populations affected by biosolid-derived or agricultural PFAS contamination.
Why Concentration-Based Regulatory Triggers Miss the Point
Regulatory frameworks that trigger treatment or remediation requirements based on total PFAS concentration above a single threshold can systematically fail to address the compound-specific nature of PFAS health risk. A source water with 30 ng/L of PFBS — below many total PFAS action levels but above PFBS-specific MCLs — would not trigger treatment under a concentration-only framework while still requiring treatment for regulatory compliance on a compound-specific basis. Similarly, a source water with 100 ng/L of PFOS would trigger action under many frameworks while being relatively tractable to treat with GAC.
The compound-specific MCLs established in the EPA 2024 NPDWR represent a regulatory evolution toward compound-level accountability that aligns better with the true nature of PFAS health risk. However, analytical monitoring that only tests for the six regulated compounds will still miss the broader compound profiles present in many source waters, leaving gaps in both health protection and treatment performance verification.
Toward Compound-Profile-Informed Treatment Policy
Water quality management agencies and utilities that have moved beyond total-PFAS monitoring to compound-level characterization are better positioned to match treatment technology to actual contamination profiles. The investment in expanded analytical monitoring — while costly per sample — pays dividends in more defensible treatment selection, more accurate service life prediction, and more robust regulatory compliance documentation.
The compound mix matters more than the concentration because it determines both the health risk and the technology required to address it. Treatment decisions made on the basis of concentration alone, without compound-level data, will systematically underinvest in short-chain PFAS removal in both urban and rural settings where short-chain compounds constitute a significant fraction of total PFAS exposure.